Source:http://linkedlifedata.com/resource/pubmed/id/11168828
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-2-22
|
pubmed:abstractText |
Following DNA immunization of rhesus macaques with a plasmid encoding the human immunodeficiency virus (HIV)-1 third variable domain (V3) loop, presented by pseudo-viral envelope particles of hepatitis B virus, specific immune responses were induced. The primates were then inoculated with a chimeric simian/human immunodeficiency virus (SHIV). All the animals were infected, but the V3-specific immunization provided a relative attenuation of the acute phase of infection in the absence of neutralizing antibody. In all animals, SHIV-specific cytotoxic T-lymphocyte precursors (CTLp) were detected early in peripheral blood and lymph nodes. The viremia peak correlated significantly with the decrease in CD4+ T cells and with a transient increase in the percentage of natural killer cells. The infection induced an oligoclonalization of the CD8+ T-cell variable beta chain repertoire in the blood. Surprisingly, HIV envelope-specific CTLp generated by genetic immunization may be governed by distinct circulation rules compared to SHIV-specific CTLp induced by infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp120,
http://linkedlifedata.com/resource/pubmed/chemical/HIV envelope protein gp120 (305-321),
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, DNA
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0047-2565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
371-86
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11168828-AIDS Vaccines,
pubmed-meshheading:11168828-Animals,
pubmed-meshheading:11168828-Antibodies, Viral,
pubmed-meshheading:11168828-Blotting, Western,
pubmed-meshheading:11168828-CD4 Lymphocyte Count,
pubmed-meshheading:11168828-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11168828-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:11168828-HIV Envelope Protein gp120,
pubmed-meshheading:11168828-HIV-1,
pubmed-meshheading:11168828-Macaca mulatta,
pubmed-meshheading:11168828-Peptide Fragments,
pubmed-meshheading:11168828-Phenotype,
pubmed-meshheading:11168828-Polymerase Chain Reaction,
pubmed-meshheading:11168828-Simian Acquired Immunodeficiency Syndrome,
pubmed-meshheading:11168828-Time Factors,
pubmed-meshheading:11168828-Vaccines, DNA,
pubmed-meshheading:11168828-Viral Load
|
pubmed:year |
2000
|
pubmed:articleTitle |
Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization.
|
pubmed:affiliation |
Laboratoire d'Immunopathologie Virale, URA CNRS 1930, Institut Pasteur, Paris, France. riviere@pasteur.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|